Establishment and characterization of ci
β
Weon-Seon Hong; Nagahiro Saijo; Yasutsuna Sasaki; Koichi Minato; Hidehiko Nakano
π
Article
π
1988
π
John Wiley and Sons
π
French
β 639 KB
Human lung cancer sublines resistant t o cisplatin (CDDP) have been developed by continuously exposing cells to gradually increasing doses of CDDP and use of the limiting dilution technique. The cell lines used were PC-7, PC-9 and PC-14 (pulmonary adenocarcinoma) and H69 and N23 I (small-cell lung c